The new tests can open a window into the duration of immunity and to the antibody levels needed to sustain it. But first, a universal standard is needed to ensure results are comparable between tests.
The coronavirus has managed to inculcate itself into every nook and cranny of our lives. We need a testing regime that is equally pervasive, repeatable and unrelenting.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
Verily, Alphabet’s life sciences arm, is launching a new study to better understand the immune response to Covid-19 and gain more information on the accuracy of tests.
Potential for testing variability, lack of standardization and lack of clarity about whether having antibodies against the virus that causes Covid-19 after infection can confer immunity are among the issues that remain unsettled.
In guidance released this weekend, the Center for Medicare and Medicaid Services is requiring private insurers to waive out-of-pocket costs for antibody testing for Covid-19.